Hypothesis: Diabetes Mellitus and Oral Lichen Ruber Disturb IGF-1/2, Increasing Malignant Transformation Risk
Background
Diabetes Mellitus is a prevalent chronic disease significantly impacting oral health. A common oral mucosal complication in diabetic patients is oral lichen ruber (OLR), classified by WHO as a potentially malignant disorder. OLR in diabetes often presents with a more aggressive course, featuring atrophic-erosive and ulcerative lesions, and an elevated risk of malignant transformation. While OLR's etiology remains unclear, evidence points to cell-mediated autoimmune pathogenesis. OLR epithelial cells exhibit anomalies in enzymatic activity and carbohydrate metabolism, potentially linked to hormones like insulin and insulin-like growth factors 1 and 2 (IGF-1 and IGF-2), which regulate carbohydrate metabolism.
Study Design
The abstract outlines a research hypothesis to investigate the association between diabetes mellitus, oral lichen ruber, and IGF-1 and IGF-2 levels. The proposed study aims to compare IGF-1 and IGF-2 disturbances in patients with diabetes and OLR lesions against those with OLR without diabetes and healthy controls. However, the abstract does not detail the specific methodology, patient cohorts, sample sizes, or measurement techniques employed in this research.
Why It Matters
If this hypothesis is confirmed, it could establish IGF-1 and IGF-2 as crucial biomarkers for assessing malignant transformation risk in oral lichen ruber patients with diabetes mellitus. This finding would highlight a novel mechanism linking metabolic dysfunction to oral cancer progression, potentially guiding earlier intervention strategies or more aggressive monitoring for high-risk individuals. It suggests that managing systemic metabolic health, particularly diabetes, could be critical in mitigating oral cancer risk in susceptible populations.